missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Retifanlimab Recombinant Monoclonal Antibody
Recombinant Monoclonal Antibody
Marke: Invitrogen™ MA559726
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.
Retifanlimab (INCMGA-0012) is an anti-PD-1 monoclonal antibody. INCMGA0012 is currently in the clinical proof-of-concept (PoC) stage. At the same time, Incyte is exploring the efficacy of INCMGA0012 monotherapy in high satellite unstable endometrial cancer and Merkel cell carcinoma.
Spezifikation
| Retifanlimab Humanized | |
| Recombinant Monoclonal | |
| Unconjugated | |
| INCMGA-00012; MGA-012 | |
| Protein A | |
| RUO | |
| Human | |
| Antibody | |
| IgG1 |
| ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance | |
| 1 mg/mL | |
| 25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2 | |
| Human | |
| 1 mg | |
| Primary | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Lyophilized |
Name des Produkts
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?